Cargando…
Plasma urea cycle metabolite levels and the risk of moyamoya disease
BACKGROUND AND PURPOSE: Urea cycle metabolites are expected to be the biomarkers for cerebrovascular diseases. However, the effects of circulating urea cycle metabolites on the risk of MMD and its subcategories remain unclear. The aim of this study was to prospectively investigate the association be...
Autores principales: | Yu, Xiaofan, Ge, Peicong, Zhai, Yuanren, Liu, Wei, Zhang, Qian, Ye, Xun, Liu, Xingju, Wang, Rong, Zhang, Yan, Zhao, Jizong, Zhang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363741/ https://www.ncbi.nlm.nih.gov/pubmed/37492403 http://dx.doi.org/10.3389/fnins.2023.1163733 |
Ejemplares similares
-
Gut microbiota in adults with moyamoya disease: characteristics and biomarker identification
por: Yu, Xiaofan, et al.
Publicado: (2023) -
Serum Kynurenic Acid and Kynurenine Are Negatively Associated with the Risk of Adult Moyamoya Disease
por: Yu, Xiaofan, et al.
Publicado: (2022) -
Correlation of Serum N-Acetylneuraminic Acid with the Risk of Moyamoya Disease
por: Liu, Chenglong, et al.
Publicado: (2023) -
Association of circulating branched-chain amino acids with risk of moyamoya disease
por: Zeng, Chaofan, et al.
Publicado: (2022) -
Association between methionine sulfoxide and risk of moyamoya disease
por: Li, Junsheng, et al.
Publicado: (2023)